{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:08:29Z","timestamp":1783372109515,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17100920"],"award-info":[{"award-number":["17100920"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["C7028-19G"],"award-info":[{"award-number":["C7028-19G"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["T12-710\/16-R"],"award-info":[{"award-number":["T12-710\/16-R"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ganciclovir (GCV) is widely used in solid organ and haematopoietic stem cell transplant patients for prophylaxis and treatment of cytomegalovirus. It has long been considered a mutagen and carcinogen. However, the contribution of GCV to cancer incidence and other factors that influence its mutagenicity remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective cohort study analysed genomics data for 121,771 patients who had undergone targeted sequencing compiled by the Genomics Evidence Neoplasia Information Exchange (GENIE) or Foundation Medicine (FM). A statistical approach was developed to identify patients with GCV-associated mutational signature (GCV<jats:sup>sig<\/jats:sup>) from targeted sequenced data of tumour samples. Cell line exposure models were further used to quantify mutation burden and DNA damage caused by GCV and other antiviral and immunosuppressive drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mutational profiles from 22 of 121,771 patient samples in the GENIE and FM cohorts showed evidence of GCV<jats:sup>sig<\/jats:sup>. A diverse range of cancers was represented. All patients with detailed clinical history available had previously undergone solid organ transplantation and received GCV and mycophenolate treatment. RAS hotspot mutations associated with GCV<jats:sup>sig<\/jats:sup> were present in 9 of the 22 samples, with all samples harbouring multiple GCV-associated protein-altering mutations in cancer driver genes. In vitro testing in cell lines showed that elevated DNA damage response and GCV<jats:sup>sig<\/jats:sup> are uniquely associated with GCV but not acyclovir, a structurally similar antiviral. Combination treatment of GCV with the immunosuppressant, mycophenolate mofetil (MMF), increased the misincorporation of GCV in genomic DNA and mutations attributed to GCV<jats:sup>sig<\/jats:sup> in cell lines and organoids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In summary, GCV can cause a diverse range of cancers. Its mutagenicity may be potentiated by other therapies, such as mycophenolate, commonly co-prescribed with GCV for post-transplant patients. Further investigation of the optimal use of these drugs could help reduce GCV-associated mutagenesis in post-transplant patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13073-022-01131-w","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T08:04:07Z","timestamp":1667203447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies"],"prefix":"10.1186","volume":"14","author":[{"given":"Hu","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen H. N.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Bilardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"Flensburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne A.","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Cheong","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Turski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siu T.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho W.","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Y. M.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S. Y.","family":"Huen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Alejandro","family":"Sweet-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2953-7728","authenticated-orcid":false,"given":"Jason W. H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"issue":"7","key":"1131_CR1","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","volume":"21","author":"KS Baker","year":"2003","unstructured":"Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003;21(7):1352\u20138.","journal-title":"J Clin Oncol"},{"issue":"17","key":"1131_CR2","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306(17):1891\u2013901.","journal-title":"JAMA"},{"issue":"1","key":"1131_CR3","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","volume":"9","author":"GJ Inman","year":"2018","unstructured":"Inman GJ, Wang J, Nagano A, Alexandrov LB, Purdie KJ, Taylor RG, Sherwood V, Thomson J, Hogan S, Spender LC, et al. The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature. Nat Commun. 2018;9(1):3667.","journal-title":"Nat Commun"},{"issue":"6","key":"1131_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","volume":"378","author":"D Dierickx","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378(6):549\u201362.","journal-title":"N Engl J Med"},{"issue":"4","key":"1131_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1399-3062.2011.00714.x","volume":"14","author":"SM Hosseini-Moghaddam","year":"2012","unstructured":"Hosseini-Moghaddam SM, Soleimanirahbar A, Mazzulli T, Rotstein C, Husain S. Post renal transplantation Kaposi\u2019s sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis. 2012;14(4):338\u201345.","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"1131_CR6","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.stem.2021.07.012","volume":"28","author":"JK de Kanter","year":"2021","unstructured":"de Kanter JK, Peci F, Bertrums E, Rosendahl Huber A, van Leeuwen A, van Roosmalen MJ, Manders F, Verheul M, Oka R, Brandsma AM, et al. Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients. Cell Stem Cell. 2021;28(10):1726-1739 e1726.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"1131_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ajhg.2022.03.018","volume":"109","author":"C Palles","year":"2022","unstructured":"Palles C, West HD, Chew E, Galavotti S, Flensburg C, Grolleman JE, Jansen EAM, Curley H, Chegwidden L, Arbe-Barnes EH, et al. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome. Am J Hum Genet. 2022;109(5):953\u201360.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"1131_CR8","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1136\/gutjnl-2019-320019","volume":"69","author":"HHN Yan","year":"2020","unstructured":"Yan HHN, Siu HC, Ho SL, Yue SSK, Gao Y, Tsui WY, Chan D, Chan AS, Wong JWH, Man AHY, et al. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles. Gut. 2020;69(12):2165\u201379.","journal-title":"Gut"},{"issue":"8","key":"1131_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"Consortium APG","year":"2017","unstructured":"Consortium APG. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discov. 2017;7(8):818\u201331.","journal-title":"Cancer Discov"},{"issue":"9","key":"1131_CR10","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1158\/0008-5472.CAN-16-2479","volume":"77","author":"RJ Hartmaier","year":"2017","unstructured":"Hartmaier RJ, Albacker LA, Chmielecki J, Bailey M, He J, Goldberg ME, Ramkissoon S, Suh J, Elvin JA, Chiacchia S, et al. High-throughput genomic profiling of adult solid tumors reveals novel insights into cancer pathogenesis. Cancer Res. 2017;77(9):2464\u201375.","journal-title":"Cancer Res"},{"issue":"11","key":"1131_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka Z, Bamford S, Cole CG, Ward SA, Dunham I, Forbes SA. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat Rev Cancer. 2018;18(11):696\u2013705.","journal-title":"Nat Rev Cancer"},{"key":"1131_CR12","doi-asserted-by":"crossref","unstructured":"Lee BCH, Robinson P, Coorens T, Yan HHN, Olafsson S, Lee-Six H, Sanders M, Siu HC, Hewinson J, Yue SSK et al: Mutational landscape of normal epithelial cells in Lynch syndrome patients. Nat Commun 2022, In press.","DOI":"10.1038\/s41467-022-29920-2"},{"issue":"14","key":"1131_CR13","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"3","key":"1131_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, Getz G. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213\u20139.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"1131_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim S, Scheffler K, Halpern AL, Bekritsky MA, Noh E, Kallberg M, Chen X, Kim Y, Beyter D, Krusche P, et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods. 2018;15(8):591\u20134.","journal-title":"Nat Methods"},{"issue":"2","key":"1131_CR16","doi-asserted-by":"publisher","first-page":"e1007603","DOI":"10.1371\/journal.pcbi.1007603","volume":"16","author":"C Flensburg","year":"2020","unstructured":"Flensburg C, Sargeant T, Oshlack A, Majewski IJ. SuperFreq: integrated mutation detection and clonal tracking in cancer. PLoS Comput Biol. 2020;16(2):e1007603.","journal-title":"PLoS Comput Biol"},{"issue":"7463","key":"1131_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415\u201321.","journal-title":"Nature"},{"key":"1131_CR18","doi-asserted-by":"publisher","unstructured":"Gori K, Baez-Ortega A: sigfit: flexible Bayesian inference of mutational signatures. bioRxiv 2020:372896.\u00a0https:\/\/doi.org\/10.1101\/372896.","DOI":"10.1101\/372896"},{"issue":"7793","key":"1131_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, Boot A, Covington KR, Gordenin DA, Bergstrom EN, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578(7793):94\u2013101.","journal-title":"Nature"},{"issue":"8","key":"1131_CR20","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","volume":"28","author":"F Nadeu","year":"2022","unstructured":"Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M, Dawson KJ, Kulis M, Diaz-Navarro A, Villamor N, et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat Med. 2022;28(8):1662\u201371.","journal-title":"Nat Med"},{"issue":"Suppl B","key":"1131_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/12.suppl_B.9","volume":"12","author":"GB Elion","year":"1983","unstructured":"Elion GB. The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother. 1983;12(Suppl B):9\u201317.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1131_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.cgt.7700106","volume":"7","author":"R Thust","year":"2000","unstructured":"Thust R, Tomicic M, Klocking R, Voutilainen N, Wutzler P, Kaina B. Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: implications for gene therapeutic approaches. Cancer Gene Ther. 2000;7(1):107\u201317.","journal-title":"Cancer Gene Ther"},{"issue":"2\u20133","key":"1131_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47(2\u20133):85\u2013118.","journal-title":"Immunopharmacology"},{"issue":"12","key":"1131_CR24","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1007\/s00216-015-8554-0","volume":"407","author":"PA Billat","year":"2015","unstructured":"Billat PA, Sauvage FL, Picard N, Tafzi N, Alain S, Essig M, Marquet P, Saint-Marcoux F. Liquid chromatography tandem mass spectrometry quantitation of intracellular concentrations of ganciclovir and its phosphorylated forms. Anal Bioanal Chem. 2015;407(12):3449\u201356.","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"1131_CR25","doi-asserted-by":"publisher","first-page":"342 e341","DOI":"10.1016\/j.jtct.2020.12.012","volume":"27","author":"K Miyao","year":"2021","unstructured":"Miyao K, Terakura S, Ozawa Y, Sawa M, Kohno A, Kasahara S, Iida H, Ino K, Kusumoto S, Kasai M, et al. Comparison of transplantation outcomes after foscarnet and ganciclovir administration as first-line anti-cytomegalovirus preemptive therapy. Transplant Cell Ther. 2021;27(4):342 e341-342 e310.","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"1131_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","volume":"99","author":"P Reusser","year":"2002","unstructured":"Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D, Finke J, Cordonnier C, Link H, Ljungman P, et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002;99(4):1159\u201364.","journal-title":"Blood"},{"issue":"6","key":"1131_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s43018-021-00200-0","volume":"2","author":"X Zou","year":"2021","unstructured":"Zou X, Koh GCC, Nanda AS, Degasperi A, Urgo K, Roumeliotis TI, Agu CA, Badja C, Momen S, Young J, et al. A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage. Nat Cancer. 2021;2(6):643\u201357.","journal-title":"Nat Cancer"},{"issue":"6591","key":"1131_CR28","doi-asserted-by":"publisher","first-page":"abl9283","DOI":"10.1126\/science.abl9283","volume":"376","author":"A Degasperi","year":"2022","unstructured":"Degasperi A, Zou X, Amarante TD, Martinez-Martinez A, Koh GCC, Dias JML, Heskin L, Chmelova L, Rinaldi G, Wang VYW, et al. Substitution mutational signatures in whole-genome sequenced cancers in the UK population. Science. 2022;376(6591):abl9283.","journal-title":"Science"},{"key":"1131_CR29","unstructured":"Fang H, Yan HHN, Bilardi RA, et al. Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies. PRJNA830636, NCBI Sequence Read Archive. 2022. https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/PRJNA830636."},{"key":"1131_CR30","unstructured":"Fang H, Yan HHN, Bilardi RA, et al: Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies. PRJNA837717, NCBI Sequence Read Archive. 2022. https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/PRJNA837717"},{"key":"1131_CR31","doi-asserted-by":"crossref","unstructured":"Fang H, Yan HHN, Bilardi RA, et al: Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies. EGAS00001006707, EGA. 2022. https:\/\/ega-archive.org\/studies\/EGAS00001006707.","DOI":"10.1186\/s13073-022-01131-w"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01131-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-022-01131-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-022-01131-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T20:04:35Z","timestamp":1667246675000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-022-01131-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1131"],"URL":"https:\/\/doi.org\/10.1186\/s13073-022-01131-w","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"1 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of The University of Hong Kong\/Hospital Authority Hong Kong West Cluster (UW14-257 and\u00a0UW18-599) and by the Human Research Ethics Committees from the Walter & Eliza Hall Institute (project 13\/01) and Melbourne Health (project 2012.274). All patients involved consented to the use of clinical information and tissue for research. In accordance with the IRB approvals, all the research conducted conformed to the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SYL has received research sponsorship from Pfizer, Merck, Servier, and Curegenix. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}